Clinical Trial Update: A Prospective, Multicenter, Open-label 12 Week Neoadjuvant Phase II Trial Optimizing Taxane Therapy in Elderly Patients With Low Response [Phase 3]

View source ↗

Summary

This Clinical Trials update describes a multicenter, open-label Phase 3 trial focused on optimizing taxane therapy in elderly patients with early breast cancer …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Taxane therapy (taxane)

Snippet

Sponsor: West German Study Group | Conditions: Early Primary Breast Cancer | Phase 3 | Status: COMPLETED